Ostrum Asset Management US’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-5,454
Closed -$1.43M 102
2018
Q4
$1.43M Buy
+5,454
New +$1.5M 0.21% 55

Other funds holding ELV

Ostrum Asset Management US's ELV Position: Q1 2019 in Review

Ostrum Asset Management US sold out of Elevance Health (ELV) in Q1 2019, closing a stake of 5,454 shares — an estimated $1.43M sold.

Ostrum Asset Management US first reported a position in ELV in Q4 2018 and held it in 1 quarter. The position peaked at $1.43M in Q4 2018. 1,076 funds tracked by Wall St. Rank hold ELV as of Q1 2019.

  • Ostrum Asset Management US reported no remaining Elevance Health position as of Q1 2019 after selling out during the quarter.
  • Ostrum Asset Management US sold 5,454 Elevance Health shares in Q1 2019, an estimated $1.43M.
  • Ostrum Asset Management US first reported a position in Elevance Health in Q4 2018 and held it in 1 quarter.
  • Ostrum Asset Management US's Elevance Health position peaked at $1.43M in Q4 2018.
  • 1,076 funds tracked by Wall St. Rank held Elevance Health as of Q1 2019.

Based on Ostrum Asset Management US's 13F filing for Q1 2019, filed 15 May 2019.